Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Feb 12, 2022 8:59am
304 Views
Post# 34422946

RE:A poll

RE:A poll

When the science advisory table for Ontario is outlining how to better sample using rapid antigen tests (within the last 24 hours) ....the answer to your question is unequivocally, NO. Suggesting the swabbing of the cheeks and throat to more accurately sample for the Omicron variant indicates just how game changing AcuVid could be. It is now being quite clearly demonstrated that nasal swabs may no longer be the most accurate sample for covid. With approval AcuVid could be at the front of the pack instead of trailing from behind ....Jmho.

Combine that with an understanding that many companies and large institutions can ill afford to have large numbers of staff away, testing at a significant level could continue for at least the rest of 2022. We haven't even experienced a winter season with a full opening where all of the common cold, the flu and covid are circulating as they typically would ....at the same time.

GLTE ....this isn't even close to being over yet!!!


moonball32 wrote: R we scr wed Yes or no

 

<< Previous
Bullboard Posts
Next >>